InvestWiserINIFY Laboratories AB
INIFY · Oslo Børs · Healthcare
6.65NOK
+9.9%last day
Price as of 2 October 2026
Performance
1 month
+3.9%
1 year
+22.0%
3 years, per year
−19.1%
5 years, per year
–
Largest fall, 3 years
−79.9%
Below the peak now
−59.0%
Volatility, 1 year
114.2%
Return with dividends reinvested.
Key figures
P/E
negative earnings
P/B
4.5
Dividend yield
0.0%
Return on equity
−49.2%
Net margin
–
Market value
74 m USD
Quality, value and trend
Where INIFY Laboratories stands against every Nordic stock today. 100 is best.
63
Profitability and a sound balance sheet over time. Better than 63% of Nordic stocks.
6
The price measured against earnings, assets and cash flow. Better than 6% of Nordic stocks.
65
The price development over the past year. Better than 65% of Nordic stocks.
37
Quality, value and trend together. Better than 37% of Nordic stocks.
About INIFY Laboratories
INIFY Laboratories AB is a company in healthcare, listed on Oslo Børs. The share trades in NOK.
INIFY Laboratories AB provides cancer diagnostics services in Sweden. It offers prostate cancer diagnostics services. The company was incorporated in 2021 and is based in Stockholm, Sweden.
See the full analysis in InvestWiser.
The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.
See the full analysis